Results of the APG2575AU101 Study of lisaftoclax (APG-2575) combined with azacitidine (AZA) in patients with newly diagnosed (ND) or prior venetoclax–exposed myeloid malignanciesTapan M. Kadia, Yifan Zhai, Michael F. Leahy et al.|Blood|2025Cited by 2